Register

COURSE DESCRIPTION:
Please join us for Stereotactic Body Radiotherapy (SBRT) for Early-Stage Non-Small Cell Lung Cancer: The “Virtual” Lobectomy? with Andrew R. Barsky, M.D. Dr. Barsky will discuss the epidemiology, etiology, subtypes, presentation and workup of early-stage non-small cell lung cancer (NSCLC) as well as the basic treatment options and outcomes of observation for early-stage NSCLC. 

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

  • Discuss the epidemiology, etiology, subtypes, presentation and workup of early-stage non-small cell lung cancer (NSCLC).
  • Discuss the basic treatment options and outcomes of observation for early-stage NSCLC.
  • Explain the outcomes of surgery and radiotherapy for early-stage NSCLC.
  • Analyze the toxicity profile of radiotherapy for early-stage NSCLC.
  • Assess the data that have influenced optimal radiotherapy dose, fractionation and technique for early-stage NSCLC.
  • Discuss the process of radiotherapy treatment planning, safety measures and quality assurance for early-stage NSCLC.
     

FACULTY AND DISCLOSURES:

Andrew R. Barsky, M.D.
Radiation Oncologist
Lynn Cancer Institute
Boca Raton Regional Hospital
Baptist Health South Florida
Boca Raton, Florida

Andrew R. Barsky, M.D., faculty for this educational activity, is a consultant for Oncora Medical, and has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.

Session date: 
11/29/2022 - 7:30am to 8:30am EST
Location: 
Zoom
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Florida Board of Athletic Training
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Dentistry
  • 1.00 Florida Board of Dietitians
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy

Please login or register to take this course.